temozolomide
ItalyDrugs containing this active substance
-
It is an antitumoral agent used to treat specific forms of brain cancer: in adults with newly diagnosed glioblastoma multiforme (initially in combination with radiotherapy and then alone) and in children aged 3 years and older or in adults with malignant glioma (such as glioblastoma multiforme or anaplastic astrocytoma) in the event of relapse or progression after standard therapy.
Form: capsules, hard gelatin
Active substance Dosage temozolomide - ATC: L01AX03
Manufacturer: MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
-
It is an anticancer drug used to treat specific types of brain tumors: in adults with newly diagnosed glioblastoma multiforme (either in combination with radiotherapy or alone) and in children aged 3 years and older or in adults with malignant glioma (such as glioblastoma multiforme or anaplastic astrocytoma) in the event of recurrence or progression after standard therapy.
Form: capsules, hard gelatin
Active substance Dosage temozolomide - ATC: L01AX03
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
This medicine is an antitumoral agent used to treat specific forms of brain cancer: in newly diagnosed glioblastoma multiforme (either in combination with radiotherapy or alone) and in cases of malignant glioma (such as glioblastoma multiforme or anaplastic astrocytoma) that occur after a relapse or disease progression.
Form: capsules, hard gelatin
Active substance Dosage temozolomide - ATC: L01AX03
Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.
-
It is an antitumoral agent used to treat specific types of brain tumors. It is used in adults with newly diagnosed glioblastoma multiforme (initially in combination with radiotherapy and then alone) and in children aged 3 years and older or in adults with malignant glioma (such as glioblastoma multiforme or anaplastic astrocytoma) in the event of recurrence or progression after standard therapy.
Form: capsules, hard gelatin
Active substance Dosage temozolomide - ATC: L01AX03
Manufacturer: TEVA B.V.